Why Adicet Bio Stock Is Skyrocketing Today

Why Adicet Bio Stock Is Skyrocketing Today
·2 min read

Shares of Adicet Bio (NASDAQ: ACET) were skyrocketing 35.7% as of 11:49 a.m. ET on Monday. This huge gain came after the company announced positive interim data from its phase 1 study evaluating investigational drug ADI-001 in treating B-cell non-Hodgkin's lymphoma. Were Adicet's phase 1 results really good enough to justify the big move for the biotech stock today?

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting